Bliss Kelly's most recent trade in Teladoc Health Inc was a trade of 4,858 Restricted Stock Units done . Disclosure was reported to the exchange on May 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 4,858 | 34,009 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 4,858 | 54,919 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Sale of securities on an exchange or to another person at price $ 6.86 per share. | 30 May 2025 | 4,653 | 50,266 (0%) | 0% | 6.9 | 31,920 | Common Stock |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 3,488 | 50,061 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 3,488 | 10,464 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 1,189 | 3,564 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 May 2025 | 1,189 | 46,573 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2025 | 19,433 | 54,854 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2025 | 19,433 | 38,867 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Sale of securities on an exchange or to another person at price $ 8.42 per share. | 19 Mar 2025 | 9,470 | 45,384 (0%) | 0% | 8.4 | 79,775 | Common Stock |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 109,832 | 109,832 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 3,488 | 13,952 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 3,488 | 37,136 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Sale of securities on an exchange or to another person at price $ 9.68 per share. | 28 Feb 2025 | 2,904 | 35,421 (0%) | 0% | 9.7 | 28,122 | Common Stock |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,404 | 33,648 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,404 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,189 | 38,325 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 1,189 | 4,753 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | 29 Nov 2024 | 3,488 | 17,440 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Bliss Kelly | President, U.S. Group Health | 29 Nov 2024 | 3,488 | 34,284 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Bliss Kelly | President, U.S. Group Health | 29 Nov 2024 | 2,040 | 32,244 (0%) | 0% | 11.9 | 24,331 | Common Stock | |
| Teladoc Health Inc | Bliss Kelly | President, U.S. Group Health | 29 Nov 2024 | 1,404 | 1,404 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | 29 Nov 2024 | 1,404 | 30,796 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Bliss Kelly | President, U.S. Group Health | 29 Nov 2024 | 1,189 | 5,942 | - | - | Performance Stock Units | ||
| Teladoc Health Inc | Bliss Kelly | President, U.S. Group Health | 29 Nov 2024 | 1,189 | 29,392 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | 01 Oct 2024 | 2,631 | 29,100 (0%) | 0% | - | Common Stock | ||
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | 01 Oct 2024 | 2,631 | 0 | - | - | Restricted Stock Units | ||
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | 01 Oct 2024 | 897 | 28,203 (0%) | 0% | 8.7 | 7,783 | Common Stock |